WP5 – Development of donor selection & protection guidelines

Leader

REGION HØVEDSTADEN
DENMARK

Partners

SANQUIN, ITALIAN NATIONAL BLOOD CENTRE, ETABLISSEMENT FRANCAIS DU SANG, NHS BLOOD AND TRANSPLANT, CSL PLASMA GMBH, AARHUS UNIVERSITETSHOSPITAL, SIHTASUTUS POHJA-EESTI REGIONAALHAIGLA, BANC DE SANG I TEIXITS, BLUTSPENDEDIENST DES BAYERISCHEN ROTEN KREUZES GGMBH, UNIVERSITY OF CAMBRIDGE, BIOEF FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS, SUOMEN PUNAINEN RISTI, MINISTRY FOR HEALTH MALTA, ZAVOD REPUBLIKE SLOVENIJE ZA TRANSFUZIJSKO MEDICINO, OSTERREICHISCHES ROTES KREUZ, UNIVERSITAETSKLINIKUM HAMBURG EPPENDORF, VIESOJI ISTIAGA NACIONALINIS KRAUJO CENTRAS

In cooperation with the partners involved, the WP5 Leader will produced Guidelines for SoHO donor selection and protection, including some guiding principles. The methodology that will be used for the development of the document will consist of evaluations of donation-related risks and critical reviews of existing and emerging eligibility criteria, aiming for risk-based, tailored, flexible and consistent donor eligibility criteria.

Login